EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
37 hedge funds and large institutions have $76.1M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
37
Holders Change
-2
Holders Change %
-5.13%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
12
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
GCL
Glazer Capital LLC
New York
|
+$2.56M |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.73M |
| 3 |
D.E. Shaw & Co
New York
|
+$1.6M |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$1.58M |
| 5 |
SC
Sculptor Capital
New York
|
+$784K |
